A Novel Formulation of Glucose-Sparing Peritoneal Dialysis Solutions with l-Carnitine Improves Biocompatibility on Human Mesothelial Cells

The main reason why peritoneal dialysis (PD) still has limited use in the management of patients with end-stage renal disease (ESRD) lies in the fact that the currently used glucose-based PD solutions are not completely biocompatible and determine, over time, the degeneration of the peritoneal membr...

Descripción completa

Detalles Bibliográficos
Autores principales: Piccapane, Francesca, Bonomini, Mario, Castellano, Giuseppe, Gerbino, Andrea, Carmosino, Monica, Svelto, Maria, Arduini, Arduino, Procino, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795315/
https://www.ncbi.nlm.nih.gov/pubmed/33374405
http://dx.doi.org/10.3390/ijms22010123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795315/
https://www.ncbi.nlm.nih.gov/pubmed/33374405
http://dx.doi.org/10.3390/ijms22010123

Ejemplares similares